BG Medicine (BGMD)
|
2.04
0.00 (0.00%)
|
|
|
|
BGMD additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
BGMD Profile
•
Exchange
NASDAQ
•
Sector
Not Available
•
Industry
Not Available
•
Held by these Mutual Funds
Not Available
•
Executives
Mr. St Bancel
Exec. Chairman
Dr. Noubar B. Afeyan Ph.D.
Founder
Director Chairman of Compensation Committee and Member of Nominating & Governance Committee
Mr. Michael W. Rogers B.A. B.A.
52
Chief Financial Officer Principal Accounting Officer Exec. VP and Treasurer
Dr. Neal F. Gordon Ph.D.
Sr. VP of Biomarker Discovery
Dr. Aram Adourian Ph.D.
VP of Scientific Affairs
Exec. Chairman
Dr. Noubar B. Afeyan Ph.D.
Founder
Director Chairman of Compensation Committee and Member of Nominating & Governance Committee
Mr. Michael W. Rogers B.A. B.A.
52
Chief Financial Officer Principal Accounting Officer Exec. VP and Treasurer
Dr. Neal F. Gordon Ph.D.
Sr. VP of Biomarker Discovery
Dr. Aram Adourian Ph.D.
VP of Scientific Affairs
•
Employee Count
39
Special Offers
Competitors
| Ticker | Last trade | Change/%change | P/E ratio | |
|---|---|---|---|---|
| ABT | 34.41 | +0.02 / +0.06% | 9.24 |
BGMD earnings
Date
Actual
Expected
Prev Yr Qtr
5/15/2012
-0.38
-0.31
-0.27
3/8/2012
-0.23
-0.29
